Sandoz launches Nexmezol, treatment for digestive disorders, in South Africa
Johannesburg, August 21, 2013 – Sandoz, the generic pharmaceuticals division of Novartis, has launched Nexmezol. Nexmezol is the first generic esomeprazole in South Africa. Nexmezol is indicated for the treatment of gastro-oesophageal reflux disease (GORD), a digestive disorder that affects the lower oesophageal sphincter, the muscle connecting the oesophagus with the stomach. In South Africa alone, […]